M&A
WPX Energy Picks Up Longtime Target Felix
By Tom Terrarosa
|
Published: December 17th, 2019
The oil producer will pay $2.5 billion for the EnCap Investments portfolio company.
Insights & Analysis
Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.
Page 34
M&A
Post-Merger T-Mobile Won’t Be Maverick: States’ Expert
By Chris Nolter
|
Published: December 12th, 2019
An expert witness for the group of states suing to block T-Mobile's purchase of Sprint testified that the post-merger company would likely lose its zeal for aggressive price competition.
M&A
Merck Expands Oncology Pipeline With ArQule
Published: December 9th, 2019
The biopharmaceutical giant is paying a 107% premium for the target, which focuses on therapies for treating cancer and rare diseases.
M&A
Drinks With The Deal: Chris Varelas
By David Marcus
|
Published: December 6th, 2019
The former Citi tech investment banker and author of 'How Money Became Dangerous' talks with The Deal’s David Marcus about working at Disneyland in the 1980s, being a tech banker after the dot-com crash and investing in influencers.
M&A
Thoma Bravo Takes Instructure Private Following Review
By Steve Gelsi
|
Published: December 4th, 2019
The $2 billion bid comes after the company announced a strategic review in October and after The Deal named the information tech company a target in January.
M&A
Discipline Crucial in 2020
By Alexandra Garfinkle
|
Published: December 2nd, 2019
M&A valuations remain frothy and Ebitda adjustments are growing, panelists cautioned at The 2019 Deal Economy Conference.
Activism
Vitamin Shoppe to Emphasize Organic Growth
By Alexandra Garfinkle
|
Published: December 2nd, 2019
Vitamin Shoppe GC David Kastin said that the company will pursue organic growth, while its soon-to-be parent pursues M&A.
Activism
Activists Find New Routes to M&A Opportunities
By Ronald Orol
|
Published: December 2nd, 2019
Insurgent managers are targeting larger companies and are taking on different roles, a panel of experts told The Deal Economy's 2019 conference.
Activism
M&A, Politics, SEC Top of Mind for Activists
By Ronald Orol
|
Published: December 2nd, 2019
Schulte Roth partner Aneliya Crawford discusses activism at large-cap companies, BMY-Celgene and insurgent prospects in a second Trump or Warren administration at The Deal Economy conference.
